 Home > Medical News > Latest Medical News > Yangzijiang Pharmaceutical was fined 764 million yuan for implementing a monopoly agreement

Yangzijiang Pharmaceutical was fined 764 million yuan for implementing a monopoly agreement

 Last Update: 2021-05-10
 Source: Internet
 Author: User

Tags

companies

medicine drug

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

[Global Network Comprehensive Report] According to the State Administration for Market Regulation, in November 2019, the State Administration for Market Regulation filed an investigation into Yangzijiang Pharmaceutical Group Co.

According to investigations, from 2015 to 2019, Yangtze River Pharmaceutical Group reached agreements with downstream companies such as drug wholesalers and retail pharmacies by signing cooperation agreements, issuing price adjustment letters, and oral notices across the country (excluding Hong Kong, Macao and Taiwan regions).

Drug prices are related to the national economy and people’s livelihood, and involve major issues such as reducing the burden on people seeking medical care and enhancing people’s livelihood and welfare.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Yangzijiang Pharmaceutical was fined 764 million yuan for implementing the monopoly agreement!

04-23

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.

Yangzijiang Pharmaceutical was fined 764 million yuan for implementing a monopoly agreement

Related Articles

Yangzijiang Pharmaceutical was fined 764 million yuan for implementing the monopoly agreement!